Evidence map›Paper›PMID 22045098›Full record

Trial reportPeritoneal dialysis international : journal of the International Society for Peritoneal Dialysis

A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products.

Kar Neng Lai, Man Fai Lam, Joseph C K Leung, Loretta Y Chan, Christopher W K Lam, Iris H S Chan, Hoi Wong Chan, Chun Sang Li, Sunny S H Wong, Yiu Wing Ho and 3 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Biocompatible dialysis fluids for peritoneal dialysis.The Cochrane database of systematic reviews · 2018
    Pooled it
  2. Pooled it
  3. Effect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trials.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
    Pooled it
  4. Trial
  5. Impact of a low-glucose peritoneal dialysis regimen on fibrosis and inflammation biomarkers.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
    Trial
  6. Review
  7. Associations of neutral pH, low-GDP peritoneal dialysis solutions with patient survival, transfer to haemodialysis and peritonitis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Clinical causes of inflammation in peritoneal dialysis patients.International journal of nephrology · 2014
    Review
  14. Article
  15. Biocompatible peritoneal dialysis fluids: clinical outcomes.International journal of nephrology · 2012
    Article
  16. Baseline serum interleukin-6 predicts cardiovascular events in incident peritoneal dialysis patients.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
    Article
  17. Hydration Status of Patients Dialyzed with Biocompatible Peritoneal Dialysis Fluids.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
    Article
  18. Trials (and tribulations) of biocompatible peritoneal dialysis fluids.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Kar Neng LaiDepartment of Medicine, The University of Hong Kong, Hong Kong SAR, PR China. knlai@hkucc.hku.hk
Man Fai Lam
Joseph C K Leung
Loretta Y Chan
Christopher W K Lam
Iris H S Chan
Hoi Wong Chan
Chun Sang Li
Sunny S H Wong
Yiu Wing Ho
Au Cheuk
Matthew K L Tong
Sydney C W Tang
Chinese University of Hong Kong · CNQueen Elizabeth Hospital · CNUnited Christian Hospital · CNUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAlthough peritoneal dialysis (PD) is a widely accepted form of renal replacement therapy, concerns remain regarding the bioincompatible nature of standard PD fluid (PDF). Short-term studies of new biocompatible PDFs low in glucose degradation products (GDPs) reveal divergent results with respect to peritoneal integrity.

methodsWe studied 125 patients on maintenance PD who were assigned, by simple randomization, to receive either conventional or low-GDP PDF at PD initiation. Parameters of dialysis adequacy and peritoneal transport of small solutes were determined at initiation and after a period of maintenance PD at the time when serum and overnight effluent dialysate were simultaneously collected and assayed for various cytokines, chemokines, adipokines, and cardiac biomarkers. All patients were further followed prospectively for an average of 15 months from the day of serum and effluent collection to determine patient survival and cardiovascular events.

resultsPatients treated with conventional or low-GDP PDF were matched for sex, age, duration of dialysis, dialysis adequacy, and incidence of cardiovascular disease or diabetes. After an average of 2.3 years of PD treatment, the weekly total and peritoneal creatinine clearance, and the total and peritoneal Kt/V were comparable in the groups. However, urine output was higher in patients using low-GDP PDF despite there having been no difference between the groups at PD initiation. Patients using low-GDP PDF also experienced a slower rate of decline of residual glomerular filtration and urine output than did patients on conventional PDF. Compared with serum concentrations, effluent concentrations of tumor necrosis factor α, hepatocyte growth factor, macrophage migration inhibitory factor, interleukins 8 and 6, C-reactive protein, and leptin were found to be higher in both groups of patients after long-term PD, suggesting that the peritoneal cavity was the major source of those mediators. Compared with patients on low-GDP PDF, patients on conventional fluid showed elevated leptin and reduced adiponectin levels in serum and effluent. The effluent concentration of interleukin 8 was significantly lower in patients using low-GDP PDF. The survival rate and incidence of cardiovascular complications did not differ between these groups after maintenance PD for an average of 3.6 years.

conclusionsIt appears that low-GDP PDF results in an improvement of local peritoneal homeostasis through a reduction of chronic inflammatory status in the peritoneum.

Indexed as

Peritoneal DialysisDialysis SolutionsFemaleGlucoseHumansMaleProspective StudiesDialysis SolutionsGlucose

Identifiers

PMID22045098
PMCPMC3525436
OpenAlexW2168032466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.